EO 14398
Active Definitive Contract Awarded Last action
- Contract number
- 75N93025C00006
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,120,519
Award facts
- Opportunity
-
- Humoral Immunology Core Laboratory for AIDS Vaccine Research Pre-Solicitation · 75N93023R00012 · Posted Nov 2, 2023
- Contract value 18% obligated
-
- $5,120,519.00 Current, with exercised options
- $28,340,062.00 Potential, with all options
- Completion date 23% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $2,597,109 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,523,410 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $28.34 million definitive contract to Duke University for a nonhuman primate core humoral immunology laboratory supporting AIDS vaccine research and development on March 30, 2025, under cost-reimbursement pricing with no set-aside.
The contract supplies humoral immunology core laboratory services evaluating antibody binding, virus neutralization, Fc receptor-mediated functions, and mucosal immune responses in nonhuman primates immunized with candidate HIV/SIV vaccines, performed in compliance with Good Laboratory Practice standards. Place of performance is Durham, North Carolina. The period of performance runs from October 2023 through March 29, 2032, comprising a one-year base period and six one-year options.
In fiscal year 2025, Duke University invoiced $1.2 million against the contract and reported a labor footprint of 5.7 full-time equivalents, with all work self-performed by the prime.
Quick answers
Who was awarded contract 75N93025C00006?
75N93025C00006 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 30, 2025.
How much is contract 75N93025C00006 worth?
The government has obligated $5,120,519 on 75N93025C00006. Its potential value, with all options, is $28,340,062.
Was contract 75N93025C00006 competed?
The extent of competition for 75N93025C00006 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award